IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer

Sorry, your subscription does not allow you to view this program.

Reversible CD8 T cell–neuron cross-talk causes aging-dependent neuronal regenerative decline

Sorry, your subscription does not allow you to view this program.

Galectin-1, CD8+ Tregs and immunosuppression in colorectal cancer

Sorry, your subscription does not allow you to view this program.